Overview

Labome lists 566997 antibody products against 58324 genes, including 18816 human, 14158 mouse, and 12188 rat genes.

Labome antibody review database lists 347681 antibody applications for 19702 genes, based on 54877 formal publications. see examples: beta actin antibody, GFP antibody, HA antibody, phosphotyrosine antibody, polyhistidine antibody, and Myc antibody.

If you are looking for OriGene antibodies against a specific gene, type in gene name in the box above and search. In the resultant gene webpage, select 'antibody' link for the correct gene to go to the antibody webpage, and use the OriGene filter as the supplier.

Gene Overview
Labome antibody review database contains antibody applications for 0 genes with antibodies supplied from OriGene based on 0 formal publications.
Select Gene Review
Here are the reagent applications for a select list of genes from Labome database .
  • human LGR5 gene: 10 publications, see all LGR5 antibody reviews
    • OriGene LGR5 antibody (OriGene, TA400002) was used in flow cytometry on mouse samples (fig 4e)
    • OriGene LGR5 antibody (OriGene Technologies, TA503316) was used in immunohistochemistry on human samples (fig 1d) and in western blot on human samples (fig 1a)
    • OriGene LGR5 antibody (Acris Antibodies, TA400001) was used in flow cytometry on human samples (fig 2b)
    • OriGene LGR5 antibody (OriGene, TA503316) was used in immunocytochemistry on human samples at 1:400 (fig 9)
    • OriGene LGR5 antibody (OriGene Tech, TA503316) was used in immunocytochemistry on human samples (fig s1b) and in immunohistochemistry on human samples (fig s5)
  • human SAMHD1 gene: 4 publications, see all SAMHD1 antibody reviews
    • OriGene SAMHD1 antibody (ORIGENE, TA501956) was used in western blot on human samples at 1:1000 (fig 2f)
    • OriGene SAMHD1 antibody (Origene, 1A1) was used in immunocytochemistry on human samples (fig 3a) and in western blot on human samples (fig 5d)
    • OriGene SAMHD1 antibody (Origene, 1F6) was used in western blot on human samples (fig s4a)
    • OriGene SAMHD1 antibody (ORIGENE, TA502085) was used in immunocytochemistry on human samples (fig 10) and in western blot on human samples (fig s1)
  • human glyceraldehyde 3 phosphate dehydrogenase gene: 3 publications, see all glyceraldehyde 3 phosphate dehydrogenase antibody reviews
    • OriGene glyceraldehyde 3 phosphate dehydrogenase antibody (ZSGB-BIO, OTI2D9) was used in western blot on human samples (fig 4g)
    • OriGene glyceraldehyde 3 phosphate dehydrogenase antibody (OriGene, TA802519) was used in western blot on human samples (fig 6c)
    • OriGene glyceraldehyde 3 phosphate dehydrogenase antibody (Origene, TA802563) was used in western blot on human samples (fig 4)
  • human Smad interacting protein 1 gene: 3 publications, see all Smad interacting protein 1 antibody reviews
    • In order to report how PTEN alters breast cancer metastatic behavior, OriGene Smad interacting protein 1 antibody (OriGene Technologies, TA802113) was used in western blot on human samples at 1:500 (fig 3a)
    • OriGene Smad interacting protein 1 antibody (Origene, TA802113) was used in western blot on human samples at 1:2000 (tbl 4)
    • In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, OriGene Smad interacting protein 1 antibody (OriGene Technologies, TA802113) was used in western blot on human samples at 1:500 (fig 5)
  • human CD56 gene: 3 publications, see all CD56 antibody reviews
    • OriGene CD56 antibody (OriGene, 1G4) was used in immunohistochemistry - paraffin section on cat samples (fig 3) and in western blot on cat samples (fig 1)
    • OriGene CD56 antibody (Origene, UMAB83) was used in western blot on human samples at 1:1000 (fig s1)
  • human ZEB1 gene: 3 publications, see all ZEB1 antibody reviews
    • In order to report how PTEN alters breast cancer metastatic behavior, OriGene ZEB1 antibody (OriGene Technologies, TA802313) was used in western blot on human samples at 1:500 (fig 3a)
    • OriGene ZEB1 antibody (Origene, TA802298) was used in western blot on human samples at 1:2000 (tbl 4)
    • In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, OriGene ZEB1 antibody (OriGene Technologies, TA802313) was used in western blot on human samples at 1:500 (fig 5)
  • human PRKAR1A gene: 3 publications, see all PRKAR1A antibody reviews
    • OriGene PRKAR1A antibody (Origene, 6C7) was used in immunohistochemistry - paraffin section on human samples at 1:8000 (fig 3a)
    • OriGene PRKAR1A antibody (OriGene, 6C7) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 3a)
    • In order to study the role of LFABP loss in hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas, OriGene PRKAR1A antibody (OriGene, OTI6C7) was used in immunohistochemistry on human samples at 1:2000 (fig 3)
  • human CD68 gene: 3 publications, see all CD68 antibody reviews
    • OriGene CD68 antibody (OriGene, KP1) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1b)
    • OriGene CD68 antibody (Zhongshan Golden Bridge, OTI4G1) was used in immunohistochemistry - paraffin section on human samples (fig 1a)
    • OriGene CD68 antibody (OriGene, UM800047) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5)
  • human uracil DNA glycosylase gene: 3 publications, see all uracil DNA glycosylase antibody reviews
    • OriGene uracil DNA glycosylase antibody (OriGene, TA503755) was used in western blot on human samples (fig 1)
    • OriGene uracil DNA glycosylase antibody (Origene, 2C12) was used in immunoprecipitation on human samples (fig 1c) and in western blot on human samples (fig 2a, 3a, 6f)
    • In order to analyze the divergent interactions with UNG2 and HLTF DNA repair proteins by HIV-1 and HIV-2, OriGene uracil DNA glycosylase antibody (OriGene, TA503563) was used in western blot on human samples (fig 2)